- Home
- WDAY vs TEVA Comparison
WDAY vs TEVA Comparison
Compare WDAY & TEVA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | WDAY | TEVA |
|---|---|---|
| Founded | 2005 | 1901 |
| Country | United States | Israel |
| Employees | N/A | N/A |
| Industry | EDP Services | Biotechnology: Pharmaceutical Preparations |
| Sector | Technology | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 42.1B | 40.5B |
| IPO Year | 2012 | 1996 |
Fundamental Metrics
Financial Performance| Metric | WDAY | TEVA |
|---|---|---|
| Price | $185.71 | $36.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 34 | 8 |
| Target Price | ★ $202.50 | $38.63 |
| AVG Volume (30 Days) | ★ 4.5M | 4.4M |
| Earning Date | 05-21-2026 | 04-29-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 32.82 | ★ 183.45 |
| EPS | ★ 3.41 | N/A |
| Revenue | ★ $2,143,050,000.00 | N/A |
| Revenue This Year | $13.80 | N/A |
| Revenue Next Year | $11.30 | $2.97 |
| P/E Ratio | $54.84 | ★ N/A |
| Revenue Growth | ★ 36.55 | N/A |
| 52 Week Low | $110.36 | $18.21 |
| 52 Week High | $249.85 | $38.37 |
Technical Indicators
Market Signals| Indicator | WDAY | TEVA |
|---|---|---|
| Relative Strength Index (RSI) | 48.10 | 50.21 |
| Support Level | $113.15 | $30.42 |
| Resistance Level | $194.01 | $37.17 |
| Average True Range (ATR) | 7.96 | 1.03 |
| MACD | -3.44 | -0.22 |
| Stochastic Oscillator | 1.08 | 25.93 |
Price Performance
Historical ComparisonAbout WDAY Workday Inc.
Workday is a software company that offers human capital management, financial management, and business planning solutions for enterprises. Known for being a cloud-only software provider, Workday was founded in 2005 and is headquartered in Pleasanton, California.
About TEVA Teva Pharmaceutical Industries Limited
Teva Pharmaceutical, based in Israel, is the world's leading generic drug manufacturer. Teva derives half of its sales from North America and makes up a high-single-digit percentage of the total number of generic prescriptions in the US. It also has a significant presence in Europe, Japan, Russia, and Israel. Besides generics, Teva has a portfolio of innovative medicines and biosimilars in two main therapeutic areas: neurology and immunology. Teva also sells active pharmaceutical ingredients, offers contract manufacturing services, and owns Anda, a US-based generic and specialty drug distributor.